Article Contents ::
- 1 The Brand Name EZERAEM Has Generic Salt :: EZETIMIBE
- 2 EZERAEM Is From Company SAFE MED(MSN) Priced :: Rs. 65
- 3 EZERAEM have EZETIMIBE is comes under Sub class Anti Hyperlipidemics of Main Class Cardiovascular System
- 4 Main Medicine Class:: Cardiovascular System Sub Medicine Class :: Anti Hyperlipidemics
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
The Brand Name EZERAEM Has Generic Salt :: EZETIMIBE
EZERAEM Is From Company SAFE MED(MSN) Priced :: Rs. 65
EZERAEM have EZETIMIBE is comes under Sub class Anti Hyperlipidemics of Main Class Cardiovascular System
Main Medicine Class:: Cardiovascular System Sub Medicine Class :: Anti Hyperlipidemics
| Salt Name : OR Generic Name | Form | Price : MRP /Probable | Packing | ||
| EZETIMIBE | TAB | Rs. 65 | 10 |
| Brand Name | Company / Manufacturers | Strength | Unit | Price / 10 |
| EZERAEM | SAFE MED(MSN) | 10MG | 10 | Rs. 65 |
| Company Brand Name | Salt Combination | Main Medical Class | Sub Medical Class |
| From SAFE MED(MSN) :: EZERAEM | EZETIMIBE | Cardiovascular System | Anti Hyperlipidemics |
Indications for Drugs ::
Hyperlipidaemias, Homozygous familial sitosterolaemia, Hypercholesterolaemia
Drug Dose ::
Adult: PO Homozygous familial sitosterolaemia; Hyperlipidaemias 10 mg once daily.
Contraindication ::
Hypersensitivity; moderate to severe liver disease or unexplained serum transaminase elevation. Children <10 yr, lactation. Drug Precautions ::
Renal or mild hepatic impairment. Monitor LFTs. Immediately discontinue ezetimibe and any HMG-CoA reductase inhibitor or fibrate if myopathy is diagnosed or suspected. Exclude or treat secondary causes of dyslipidaemia prior to initiating therapy.
Drug Side Effects ::
Abdominal discomfort, headache, dizziness, sinusitis, pharyngitis; diarrhoea, chest pain, arthralgia, myalgia, resp infection and fatigue.
Pregnancy category ::
3
Drug Mode of Action ::
Ezetimibe localises at the brush border of the small intestine where it inhibits the absorption of cholesterol, thus decreasing its delivery to the liver. This results in decrease in cholesterol stores within the liver and an increase in cholesterol clearance from the blood.
Drug Interactions ::
Reduced absorption w/ colestyramine. Increased plasma concentrations w/ ciclosporin. Concomitant use w/ oral anticoagulants may result in increased INR.
